Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Heit

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
Thrombosis Research|July 7, 2015
Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort studyJohn A Heit, Brian D Lahr, Aneel A Ashrani, et al.
Blood|May 10, 2017
Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the USJohn A Heit, Daniel J Crusan, Aneel A Ashrani, et al.
Thrombosis and Haemostasis|December 16, 2016
Reasons for the persistent incidence of venous thromboembolismJohn A Heit, Aneel Ashrani, Daniel J Crusan, et al.
Thrombosis Research|October 5, 2010
Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imagingRajiv K Pruthi, Todd M Daniels, John A Heit, et al.
European Journal of Haematology|March 25, 2010
Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic considerationMichelle A Elliott, Louis Letendre, Dennis A Gastineau, et al.
Platelets|April 10, 2015
Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesiclesVirginia M Miller, Brian D Lahr, Kent R Bailey, et al.
Blood|September 6, 2011
Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort studyJohn A Heit, Brian D Lahr, Tanya M Petterson, et al.
Thrombosis Research|September 14, 2010
Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control studyMichel K Barsoum, John A Heit, Aneel A Ashrani, et al.
Thrombosis Research|April 21, 2015
Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control studyAneel A Ashrani, Michel K Barsoum, Daniel J Crusan, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2005
Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population-based case-control studyJohn A Heit, Tanya M Petterson, Whyte G Owen, et al.
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Thrombosis Research|July 7, 2015
Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort studyJohn A Heit, Brian D Lahr, Aneel A Ashrani, et al.
Blood|May 10, 2017
Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the USJohn A Heit, Daniel J Crusan, Aneel A Ashrani, et al.
Thrombosis and Haemostasis|December 16, 2016
Reasons for the persistent incidence of venous thromboembolismJohn A Heit, Aneel Ashrani, Daniel J Crusan, et al.
Thrombosis Research|October 5, 2010
Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imagingRajiv K Pruthi, Todd M Daniels, John A Heit, et al.
European Journal of Haematology|March 25, 2010
Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic considerationMichelle A Elliott, Louis Letendre, Dennis A Gastineau, et al.
Platelets|April 10, 2015
Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesiclesVirginia M Miller, Brian D Lahr, Kent R Bailey, et al.
Blood|September 6, 2011
Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort studyJohn A Heit, Brian D Lahr, Tanya M Petterson, et al.
Thrombosis Research|September 14, 2010
Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control studyMichel K Barsoum, John A Heit, Aneel A Ashrani, et al.
Thrombosis Research|April 21, 2015
Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control studyAneel A Ashrani, Michel K Barsoum, Daniel J Crusan, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2005
Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population-based case-control studyJohn A Heit, Tanya M Petterson, Whyte G Owen, et al.
Pageof 15